Stock Analiz

Palatin Technologies Inc. PTN

Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026

$6.23Market cap $11M
Open the interactive analysis →

Palatin Technologies Inc. (PTN) is a healthcare company listed in the US with a market value of about $11M. In fiscal year 2026 it had revenue of $13M and net income of -$8M, a net margin of -63.5%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -1476%.

About Palatin Technologies

Palatin Technologies is listed in the US and classified in biotechnology: pharmaceutical preparations. Revenue went from $13M in 2015 to $13M in 2026, growth of about 0.2% a year. It was profitable in 3 of the last 10 years in our data. Its share count fell by 74% over three years (buybacks). It spends 94% of revenue on research and development.

Score: 1.2 / 5

Value0/5
Future growth3/5
Track record0/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Share count down over 3 years (buybacks)

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.8
P/B1.7
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-122.4%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-921.5%
ROIC (5-yr avg.)-1475.5%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 10 years

Fiscal year2026202520242023202220212020201920182017
Revenue$13M$0$4M$5M$1M-$188597$117989$60M$67M$67M
Net income-$8M-$17M-$30M-$24M-$36M-$34M-$22M$36M$25M$25M
Free cash flow-$14M-$21M-$32M-$30M-$30M-$99360$41M-$22M$2M$13M
EPS (diluted)$-2.96$-32.15$-101.16$-2.21—$-0.14$-0.10$0.16$0.12$0.12
Net margin-63.5%—-662.3%-495.2%-2465.1%17813.9%-19006.9%59.3%36.8%36.8%
ROIC-99.1%—-4106.0%—-221.5%-51.8%-22.9%27.9%61.6%223.4%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Palatin Technologies pay a dividend?

Not currently.

Is Palatin Technologies a good stock to buy?

We do not give buy or sell advice. Palatin Technologies scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.